FR2829392B1 - Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire - Google Patents
Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaireInfo
- Publication number
- FR2829392B1 FR2829392B1 FR0111627A FR0111627A FR2829392B1 FR 2829392 B1 FR2829392 B1 FR 2829392B1 FR 0111627 A FR0111627 A FR 0111627A FR 0111627 A FR0111627 A FR 0111627A FR 2829392 B1 FR2829392 B1 FR 2829392B1
- Authority
- FR
- France
- Prior art keywords
- crmps
- dysfunction
- medicament
- manufacture
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0111627A FR2829392B1 (fr) | 2001-09-07 | 2001-09-07 | Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire |
ES02774915T ES2369354T3 (es) | 2001-09-07 | 2002-09-09 | Utilización de una proteina de la familia de las crmps para el tratamiento de enfermedades ligadas al sistema inmunitario. |
JP2003526426A JP4499414B2 (ja) | 2001-09-07 | 2002-09-09 | 免疫系に関する疾病を治療するためのcrmpファミリーのタンパク質の使用 |
CA002461692A CA2461692A1 (fr) | 2001-09-07 | 2002-09-09 | Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
AT02774915T ATE517629T1 (de) | 2001-09-07 | 2002-09-09 | Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems |
PCT/FR2002/003056 WO2003022298A2 (fr) | 2001-09-07 | 2002-09-09 | Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
AU2002341090A AU2002341090A1 (en) | 2001-09-07 | 2002-09-09 | Use of a protein of the crmp family for treating diseases related to the immune system |
US10/488,554 US7820375B2 (en) | 2001-09-07 | 2002-09-09 | Use of a protein of the CRMP family for treating diseases related to the immune system |
EP02774915A EP1435993B1 (fr) | 2001-09-07 | 2002-09-09 | Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0111627A FR2829392B1 (fr) | 2001-09-07 | 2001-09-07 | Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2829392A1 FR2829392A1 (fr) | 2003-03-14 |
FR2829392B1 true FR2829392B1 (fr) | 2005-09-16 |
Family
ID=8867087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0111627A Expired - Fee Related FR2829392B1 (fr) | 2001-09-07 | 2001-09-07 | Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2369354T3 (fr) |
FR (1) | FR2829392B1 (fr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2759701B1 (fr) * | 1997-02-19 | 1999-06-04 | Inst Nat Sante Rech Med | Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques |
FR2805540B1 (fr) * | 2000-02-29 | 2004-04-09 | Inst Nat Sante Rech Med | Nouvelle proteine ulip humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques |
-
2001
- 2001-09-07 FR FR0111627A patent/FR2829392B1/fr not_active Expired - Fee Related
-
2002
- 2002-09-09 ES ES02774915T patent/ES2369354T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2369354T3 (es) | 2011-11-29 |
FR2829392A1 (fr) | 2003-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1434594A4 (fr) | Analogues de cyclosporine pour le traitement de maladies auto-immunes | |
IL159344A0 (en) | Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease | |
FR2840804B1 (fr) | Systeme pour le traitement de l'obesite et implant pour un tel systeme | |
DZ3500A1 (fr) | Derives de phenethanolamine pour le traitement de maladies respiratoires | |
IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
HUP0200994A3 (en) | Remedies for immunological diseases | |
IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
EE04156B1 (et) | Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks | |
IL145470A0 (en) | Compositions for the treatment of immune diseases | |
NO20041882L (no) | Fremgangsmater for behandling av okulare neovaskulaere sykdommer. | |
AU2003285091A8 (en) | Interferon antagonists useful for the treatment of interferon related diseases | |
EE200300214A (et) | Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks | |
EP1404343A4 (fr) | Combinaisons therapeutiques pour le traitement des carences hormonales | |
CH1143977H1 (fr) | 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite | |
EP1463527A4 (fr) | Utilisation de gammaglobuline pour le traitement de maladies d'origine immunologique | |
DZ3014A1 (fr) | Médicaments pour le traitement de l'hypertension. | |
ITTO940748A0 (it) | Condotto protesico particolarmente per il trattamento di patologie cardiovascolari. | |
FR2826232B1 (fr) | Releveur d'epis pour systemes de fauchage de machines de recolte | |
MA26841A1 (fr) | Composes pour traiter les maladies pulmonaires | |
MA25852A1 (fr) | Methode pour le traitement de l'inflammation. | |
FR2829392B1 (fr) | Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire | |
AU2002254947A1 (en) | Kappa opiate agonists for the treatment of bladder diseases | |
EE200200693A (et) | Interferoon hulgiskleroosi raviks | |
NO20001894D0 (no) | Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer | |
EP1252895A4 (fr) | Remedes pour troubles ophtalmiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20090529 |